Từ điển y khoa

Thuật ngữ y khoa chuẩn hóa theo MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5819873-(3-((3,5-dichlorophenyl)thio)-6-methyl-1H-indol-2-yl)propanamideMeSH

  structure in first source

• C5766513-(3-(1,2,4)-triazolo)-oxatriazolium-5-olateMeSH
• C5769493-(3-(4-(3-(glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)-3-methylphenoxy)propylamino)propionamideMeSH

  structure in first source

• C5779273-(3-(4-(4-(2H-tetrazole-5-yl)phenoxy)butoxy)-4-methoxyphenyl)-1-cycloheptyl-4,4-dimethyl-1H-pyrazol-5(4H)-oneMeSH

  an trypanocidal agent that inhibits trypanosomal phosphodiesterases B1 and B2; structure in first source

• C5618963-(3-(pyridine-3-yl)-1,2,4-oxadiazol-5-yl)benzonitrileMeSH

  an alpha4beta2 nAChR agonist

• C5612313-(3-(quinolin-2-ylamino)phenyl)acrylic AcidMeSH

  a RhoA inhibitor with vasorelaxant activity; structure in first source

• C5791193-(3-(quinoxalin-3-ylamino)phenyl)acrylic acidMeSH

  structure in first source

• C5612303-(3-(quinoxalin-3-ylamino)phenyl)prop-2-en-1-olMeSH

  a RhoA inhibitor with vasorelaxant activity; structure in first source

• C5694343-(3-amino-3-carboxypropyl)-5,6-dihydrouridineMeSH

  structure in first source

• C5715273-(3-benzoylbenzylidene)-6-((5-tert-butyl-1H-imidazol-4-yl)methylene)piperazine-2,5-dioneMeSH

  an antimicrotubule agent; structure in first source

• C5793393-(3-bromothiophen-2-yl)-8-methyl-8-azabicyclo(3.2.1)oct-2-eneMeSH

  structure in first source

• C5695013-(3-chloro-1,4-naphthoquinon-2-yl)-2-methylpropenoic acidMeSH

  an AP endonuclease 1 inhibitor; structure in first source

• C5766423-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazoleMeSH

  structure in first source

• C5602713-(3-chlorophenoxymethyl)-1-(tetrahydropyran-4-yl)-1H-pyrazolo(3,4-d)pyrimidin-4-ylamineMeSH

  inhibits casein kinase 1 epsilon; structure in first source

• C5762723-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-oneMeSH

  has antineoplastic activity; structure in first source

• C5831583-(3-imidazol-1-ylmethylphenyl)-5-isobutylthiophene-2-(N-butyloxycarbonyl)sulfonamideMeSH

  structure in first source

• C5877923-(3-methyl-1,2,4-oxadiazol-5-yl)-1-(3-(4-octylphenoxy)-2-oxopropyl)indole-5-carboxylic acidMeSH

  structure in first source

• C5754393-(3-tert-butyl-6,8-difluoro(1,2,4)triazolo(4,3-a)pyridin-7-yl)-N-cyclopropyl-5-fluoro-4-methylbenzamideMeSH

  structure in first source

• C5616853-(4'-(4'-fluorophenyl)-6'-phenylpyrimidin-2'-yl)-2-phenylthiazolidin-4-oneMeSH

  an antineoplastic agent; structure in first source

• C5857383-(4,5-dihydrooxazol-2-yl)phenyl (5-fluoropentyl)carbamateMeSH

  used as a probe of fatty acid amide hydrolase; structure in first source

• C5616903-(4,8,12,16-tetramethyl-heptadeca-3,7,11,15-tetraenyl)thiophene-1-oxideMeSH

  antineoplastic from the Sikao Bay sponge, Xestospongia sp.; structure in first source

• C5781983-(4-((2'-fluoro-5'-methoxy-(1,1'-biphenyl)-4-yl)methoxy)phenyl)hex-4-enoic acidMeSH

  a free fatty acid 1 receptor partial agonist; structure in first source

• C5685103-(4-((2,6-dichloropyridin-4-yl)ethynyl)phenyl)propanoic acidMeSH

  a free fatty acid receptor 1 (FFA1) agonist; structure in first source

• C5781993-(4-((4'-chloro-2'-ethoxy-(1,1'-biphenyl)-4-yl)methoxy)phenyl)hex-4-ynoic acidMeSH

  a free fatty acid 1 receptor partial agonist; structure in first source

• C5850653-(4-((4-fluoro-4'-methyl-(1,1'-biphenyl)-2-yl)methoxy)phenyl)propanoic acidMeSH

  an agonist of long chain free fatty acid receptor 4 (FFA4), aka GPR120; structure in first source

• C5883993-(4-(1-piperidinylmethyl)phenyl)-9H-pyrrolo(2,3-b-5,4-c')dipyridine-6-carbonitrileMeSH

  a ChK1 inhibitor; structure in first source

• C5772803-(4-(2-(diethylamino) ethoxy)phenyl)-7-methoxy-4-methylcoumarinMeSH

  structure in first source

• C5772813-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-7-methoxy-4-phenylcoumarinMeSH

  structure in first source

• C5614293-(4-(3-chlorophenyl)-1-ethyl-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-3-yl)propanoic acidMeSH

  a phosphodiesterase-4 inhibitor; structure in first source

• C5745513-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonylamino)-3-methyl-5-isoxazolyl)benzylsulfanyl)propanoic acid methyl esterMeSH
• C5790353-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidineMeSH

  structure in first source

• C5727613-(4-(4-cyclohexylpiperazin-1-yl)pentyl)-6-fluorobenzo(d)thiazol-2(3H)-oneMeSH

  AZ66 is a sigma receptor ligand; structure in first source

• C5840103-(4-(4-cyclohexylpiperazine-1-yl)pentyl)-6-fluorobenzo(d)thiazole-2(3H)-oneMeSH

  a sigma receptor ligand; structure in first source

• C5864503-(4-(benzo(d)(1,3)dioxol-5-yl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-oneMeSH

  an mTOR pathway inhibitor; structure in first source

• C5791333-(4-(benzo(d)(1,3)dioxol-5-yl)-2-oxobut-3-en-1-ylidene)indolin-2-oneMeSH

  an aurora B kinase inhibitor; structure in first source

• C5741793-(4-(cyclopropylsulfonyl)phenoxy)-5-((3-methylbut-2-en-1-yl)oxy)-N-(thiazol-2-yl)benzamideMeSH

  structure in first source

• C5704713-(4-(dimethoxy-O-phosphorothioyl)phenyl)propanoic acidMeSH

  structure in first source

• C5694833-(4-(ethylthio)-1H-benzimidazol-2-yl)isoquinolineMeSH

  structure in first source

• C5810073-(4-(phenylamino)phenylcarbamoyl)acrylic acidMeSH

  structure in first source

• C5724573-(4-(tert-octyl)phenoxy)propane-1,2-diolMeSH

  an NSAID; structure in first source

• C5841673-(4-O-triphenylphosphoniumbutyl)quercetin iodideMeSH
• C5871713-(4-amino-1,2,5-oxadiazol-3-yl)-4-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazoleMeSH

  structure in first source

• C5746483-(4-amino-3-fluoro-5-((1,1,1-trifluoro-3-methoxypropan-2-yl)oxy)benzyl)-5-((3-(tert-butyl)benzyl)amino)-4-hydroxytetrahydro-2H-thiopyran 1,1-dioxideMeSH

  a BACE1 inhibitor; structure in first source

• C5746473-(4-amino-3-fluoro-5-(2,2,2-trifluoroethoxy)benzyl)-5-((3-(tert-butyl)benzyl)amino)-4-hydroxytetrahydro-2H-thiopyran 1,1-dioxideMeSH

  a BACE1 inhibitor; structure in first source

• C5695943-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl esterMeSH

  structure in first source

• C5716613-(4-bromobenzyl)-5-(1H-indol-3-yl-methylene)-2-thioxoimidazolidin-4-oneMeSH

  has anti-inflammatory and antinociceptive activities

• C5622323-(4-chlorobenzyl)-5-(4-nitrobenzylidene)imidazolidine-2,4-dioneMeSH

  a schistosomicide; structure in first source

• C5878133-(4-chlorophenyl) glutaric acid diamideMeSH

  structure in first source

• C5769513-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)pyrazolo(3,4-d)azepine 2-hydroxy-1,2,3-propanetricarboxylateMeSH

  a 5-HT7 antagonist

• C5881423-(4-chlorophenyl)-4-(3,4-dichlorophenyl)pyrrolidin-2-oneMeSH

  also has norepinephrine reuptake inhibitory activity; structure in first source